先进制造业知识服务平台
国家科技图书文献中心机械分馆  工信部产业技术基础公共服务平台  国家中小企业公共服务示范平台

OA期刊


ISSN1942-0862
刊名Mabs
出版商Taylor & Francis Inc.
urlhttps://www.tandfonline.com/loi/kmab20
机构Taylor & Francis Ltd.



全部

2010 2011 2012 2013 2014 2015
2016 2017 2018 2019 2020 2021
2022 2023 2024 2025

2014, vol.6, no.1 2014, vol.6, no.2 2014, vol.6, no.3 2014, vol.6, no.4 2014, vol.6, no.5 2014, vol.6, no.6

题名作者出版年年卷期
Interference of HCV replication by cell penetrable human monoclonal scFv specific to NS5B polymeraseKanyarat Thueng-in;Jeeraphong Thanongsaksrikul;Surasak Jittavisutthikul;Watee Seesuay;Monrat Chulanetra;Yuwaporn Sakolvaree;Potjanee Srimanote;Wanpen Chaicumpa;20142014, vol.6, no.5
Framework selection can influence pharmacokinetics of a humanized therapeutic antibody through differences in molecule chargeBing Li;Devin Tesar;C Andrew Boswell;Hendry S Cahaya;Anne Wong;Jianhuan Zhang;Y Gloria Meng;Charles Eigenbrot;Homer Pantua;Jinyu Diao;Sharookh B Kapadia;Rong Deng;Robert F Kelley;20142014, vol.6, no.5
A novel approach to investigate the effect of methionine oxidation on pharmacokinetic properties of therapeutic antibodiesJan Stracke;Thomas Emrich;Petra Rueger;Tilman Schlothauer;Lothar Kling;Alexander Knaupp;Hubert Hertenberger;Andreas Wolfert;Christian Spick;Wilma Lau;Georg Drabner;Ulrike Reiff;Hans Koll;Apollon Papadimitriou;20142014, vol.6, no.5
Effect of antigen-dependent clearance on pharmacokinetics of anti-heparin-binding EGF-like growth factor (HB-EGF) monoclonal antibodyNoriyuki Kasai;Yukitaka Yoshikawa;Junichi Enokizono;20142014, vol.6, no.5
Effect of formulation on the stability and aerosol performance of a nebulized antibodyRenaud Respaud;Denis Marchand;Christelle Parent;Thibaut Pelat;Philippe Thullier;Jean-François Tournamille;Marie-Claude Viaud-Massuard;Patrice Diot;Mustapha Si-Tahar;Laurent Vecellio;Nathalie Heuzé-Vourc’h;20142014, vol.6, no.5
Biosimilars entering the clinic without animal studiesLeon AGJM van Aerts;Karen De Smet;Gabriele Reichmann;Jan Willem van der Laan;Christian K Schneider;20142014, vol.6, no.5
In vitro and in vivo modifications of recombinant and human IgG antibodiesHongcheng Liu;Gomathinayagam Ponniah;Hui-Min Zhang;Christine Nowak;Alyssa Neill;Nidia Gonzalez-Lopez;Rekha Patel;Guilong Cheng;Adriana Z Kita;Bruce Andrien;20142014, vol.6, no.5
The human Müllerian inhibiting substance type II receptor as immunotherapy target for ovarian cancerNathalie Kersual;Véronique Garambois;Thierry Chardès;Jean-Pierre Pouget;Imed Salhi;Caroline Bascoul-Mollevi;Frédéric Bibeau;Muriel Busson;Henri Vié;Béatrice Clémenceau;Christian K Behrens;Pauline Estupina;André Pèlegrin;Isabelle Navarro-Teulon;20142014, vol.6, no.5
Regulation of complement and modulation of its activity in monoclonal antibody therapy of cancerSaskia Meyer;Jeanette HW Leusen;Peter Boross;20142014, vol.6, no.5
Inhibitors of SRC kinases impair antitumor activity of anti-CD20 monoclonal antibodiesMagdalena Winiarska;Kamil Bojarczuk;Beata Pyrzynska;Jacek Bil;Marta Siernicka;Michal Dwojak;Malgorzata Bobrowicz;Nina Miazek;Piotr Zapala;Agnieszka Zagozdzon;Magdalena Krol;Aleksandra Syta;Paulina Podszywalow-Bartnicka;Zofia Pilch;Anna Dabrowska-Iwanicka;Przemyslaw Juszczynski;Dimitar G Efremov;Mikolaj Slabicki;Thorsten Zenz;Aude Le Roy;Daniel Olive;Tomasz P Rygiel;Jeanette HW Leusen;Jakub Golab;20142014, vol.6, no.5
123